AI assistant
Cigna Group — Director's Dealing 2022
Mar 2, 2022
29918_dirs_2022-03-01_92e49645-4877-4b14-9d6c-b190998aa3fe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cigna Corp (CI)
CIK: 0001739940
Period of Report: 2022-02-25
Reporting Person: Neville Everett (EVP, Strat, Corp Dev/Solutions)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-25 | Common Stock, $.01 Par Value | A | 1414.0000 | $0.0000 | Acquired | 9635.0000 | Direct |
| 2022-02-25 | Common Stock, $.01 Par Value | F | 224.0000 | $229.6400 | Disposed | 9411.0000 | Direct |
| 2022-02-25 | Common Stock, $.01 Par Value | F | 415.0000 | $229.6400 | Disposed | 8996.0000 | Direct |
| 2022-02-28 | Common Stock, $.01 Par Value | S | 268.0000 | $228.7000 | Disposed | 8728.0000 | Direct |
Footnotes
F1: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2019-2021 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
F2: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
F3: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
F4: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021.